Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy.
Megu Yamaguchi BadenAkihisa ImagawaNorio AbiruTakuya AwataHiroshi IkegamiYasuko UchigataYoichi OikawaHaruhiko OsawaHiroshi KajioEiji KawasakiYumiko KawabataJunji KozawaAkira ShimadaKazuma TakahashiShoichiro TanakaDaisuke ChujoTomoyasu FukuiJunnosuke MiuraKazuki YasudaHisafumi YasudaTetsuro KobayashiToshiaki Hanafusanull nullPublished in: Diabetology international (2018)
Anti-programmed cell death-1 antibody-related type 1 diabetes varies from typical fulminant type 1 diabetes to acute-onset type 1 diabetes. However, diabetic ketoacidosis was frequently observed at the onset of diabetes. An appropriate diagnosis and treatment should be provided to avoid life-threatening metabolic alterations.